Clinical Perspectives

The Critical Role of Surgeon Selection in Cancer Outcomes

Moffitt Cancer Center performs 850-900 cancer surgeries monthly. This case volume supports genuine subspecialization, where surgeons focus...

Oncoplastic Surgery: Advancement in Breast Cancer Surgery

As a referring provider, it's crucial to understand that oncoplastic surgery is now an integral component of all breast cancer surgeries

Expanding Access: Cellular Therapies and Autologous Stem Cell Transplants for Treatment-Resistant Autoimmune Disease

Moffitt has launched a new service specifically for non-cancer patients with autoimmune diseases like MS and SSc or Scleroderma who have relapsed...

New Treatments for Breast Cancer Leptomeningeal Disease Using the Patients' Own Immune Cells

LMD often emerges paradoxically when the systemic disease appears well-controlled, it creates a devastating disconnect between overall cancer...

Revolutionizing Breast Cancer Treatment: Personalized Immunotherapy Trials at Moffitt Cancer Center

In the evolving landscape of breast cancer treatment, two groundbreaking clinical trials at Moffitt are offering new hope to patients with aggressive...

Expanding Treatment Horizons: Moffitt's Approach to Stage IV Esophageal Cancer Surgery

Historically, surgery has been considered inappropriate for patients with stage IV esophageal cancer, but Moffitt's experts suggested that...

Improving Survival Rates in Esophageal Cancer: Why Early Referral Matters

Early referral to Moffitt provides esophageal cancer patients access to world-class GI cancer expertise.

Expanding Minimally Invasive Options for Lung Metastases: The Role of Thermal Ablation

Moffitt Cancer Center has been working to expand access to thermal ablation for appropriate patients in the Southeast.

6 Common Bone Marrow Transplant Misconceptions for Leukemia Patients

If you have a patient with leukemia or hematologic malignancy, but you are unsure if they are eligible for bone marrow transplant, we encourage you...

The Power of Investigator-Initiated Trials

Discover how physician-led clinical trials at Moffitt are driving cancer breakthroughs and giving more patients access to promising new therapies.

Understanding MGUS: Why Early Monitoring Can Be Life-Changing

Mal Heme, Malignant Hematology, high-risk, patients Monoclonal Gammopathy of Undetermined Significance (MGUS)

From Clinical Trial to Standard of Care: Pembrolizumab Plus Chemoradiotherapy Available at Moffitt

The introduction of immunotherapy into the curative-intent setting has prompted a meaningful shift in cervical cancer treatment.

Now Enrolling: Novel Dendritic Cell Vaccines Immunotherapy Trial For HER2+ Breast Cancer

Dendritic cell vaccines study offers hope for a less toxic, more personalized approach for the treatment of HER2 breast cancer with less chemotherapy...

One of Only Five Multidisciplinary Cutaneous Lymphoma Clinics in U.S. is at Moffitt

Cutaneous lymphomas are a heterogenous group of lymphoproliferative disorders that present in the skin and are composed of malignant clonal T- or...

Q&A: Understanding Intralesional and Infusional Therapies for Metastatic Melanoma

Dr. Matthew Perez discusses intralesional and infusional therapies for metastatic melanoma.